All Comments by Elliott Mufson

  1. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
  2. Aging and Alzheimer's disease: lessons from the Nun Study.
  3. Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease.
  4. Possible mechanisms for atrophy of the human hippocampus.
  5. Controlling amyloid beta-peptide fibril formation with protease-stable ligands.
  6. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation.
  7. Dissociation of Alzheimer type pathology in a disconnected piece of cortex.
  8. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease.
  9. Zinc and Alzheimer's disease: is there a direct link?
  10. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.
  11. Heparin promotes beta-secretase cleavage of the Alzheimer's amyloid precursor protein.
  12. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
  13. Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia.
  14. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.
  15. A computational model of the progression of Alzheimer's disease.